- Home
- Overcoming Resistance to EGFR Inhibitors in EGFR Mutant NSCLC
- Author : Anthony Faber
- Publsiher : Academic Press
- Release : 15 March 2021
- ISBN : 9780128228333
- Pages : 250 pages
- Rating : 4/5 from 21 reviews
GET THIS BOOKOvercoming Resistance to EGFR Inhibitors in EGFR Mutant NSCLC
Read or download book entitled Overcoming Resistance to EGFR Inhibitors in EGFR Mutant NSCLC written by Anthony Faber which was release on 15 March 2021, this book published by Academic Press. Available in PDF, EPUB and Kindle Format. Book excerpt: Overcoming Resistance to EGFR Inhibitors in EGFR Mutant NSCLC, Volume 17 presents updated information on how EGFR mutant lung cancers evolve to evade EGFR inhibitors, clinical strategies that identify these mechanisms, and how to implement newer therapeutic strategies to combat resistance and improve patient survival. As resistance to EGFR inhibitors is often through re-activation of MEK/ERK and PI3K pathways, or through loss of cell death responses, there is much overlap with resistance to targeted therapies in other paradigms, such as BRAF inhibitors in BRAF mutant melanoma, and HER2 inhibitors in HER2 amplified breast cancer. This book is a valuable resource for cancer researchers, clinicians, graduate students and other members of the biomedical field who are interested in promising treatments for lung cancer. Presents historical context on how NSCLC and SCLC has been treated, with an emphasis on NSCLC and how the concept of EGFR inhibitors has been implemented Discusses critical resistant mechanisms seen in the clinic to 1st, 2nd and 3rd generation EGFR inhibitors Encompasses the current state of affairs in clinical trials to address resistance
- Author : Anthony Faber
- Publisher : Academic Press
- Release Date : 2021-03-15
- Total pages : 250
- ISBN : 9780128228333
GET BOOK
Summary : Overcoming Resistance to EGFR Inhibitors in EGFR Mutant NSCLC, Volume 17 presents updated information on how EGFR mutant lung cancers evolve to evade EGFR inhibitors, clinical strategies that identify these mechanisms, and how to implement newer therapeutic strategies to combat resistance and improve patient survival. As resistance to EGFR inhibitors is ...
- Author : Caroline Amalia Nebhan
- Publisher : Unknown
- Release Date : 2014
- Total pages : 145
- ISBN : 9780128228333
GET BOOK
Summary : Download or read online Acquired Resistance to Targeted Therapy in EGFR mutant Lung Adenocarcinoma written by Caroline Amalia Nebhan, published by which was released on 2014. Get Acquired Resistance to Targeted Therapy in EGFR mutant Lung Adenocarcinoma Books now! Available in PDF, ePub and Kindle....
- Author : Marianne Davies,Beth Eaby-Sandy
- Publisher : Springer
- Release Date : 2019-07-16
- Total pages : 120
- ISBN : 9780128228333
GET BOOK
Summary : This book aims to educate nurses and advanced practice providers (APP’s) about known mutations, availability of targeted therapy and the management of patients with non-small cell lung cancer (NSCLC). It will educate nurses and practitioners about the scope of therapy to assure safe and effective lung cancer treatment. In ...
- Author : Harun M. Patel,Rahul Pawara,Sanjay J. Surana
- Publisher : Elsevier
- Release Date : 2018-11-27
- Total pages : 208
- ISBN : 9780128228333
GET BOOK
Summary : Third Generation EGFR Inhibitors: Overcoming EGFR Resistance and Toxicity Problems reviews current issues relating to the design of reversible and irreversible third generation EGFR inhibitors, highlighting the types of mutation responsible for resistance, and providing different chemical starting points for researchers to optimize and develop in designing the next generation ...
- Author : Vera Hirsh,Barbara Melosky
- Publisher : Frontiers Media SA
- Release Date : 2015-10-20
- Total pages : 212
- ISBN : 9780128228333
GET BOOK
Summary : Lung cancer is the leading cause of cancer related mortality in Canada and USA. Majority of the patients present in advanced stage of the disease and of these only about 2% will be alive at 5 years. NSCLC is the most common form of lung cancer, accounting for approximately 87% of cases. Systemic ...
- Author : Myron R. Szewczuk,Bessi Qorri,Manpreet Sambi
- Publisher : Springer
- Release Date : 2019-07-15
- Total pages : 320
- ISBN : 9780128228333
GET BOOK
Summary : Targeted therapies were initially developed to exploit the upregulation and dependence on key oncogenic pathways critical to cancer progression. Additionally, they also presented as a method to overcome chemoresistance by supplementing conventional therapeutic regimens with targeted therapies. However, the development of resistance to these combinatorial approaches has led to the ...
- Author : Anonim
- Publisher : Academic Press
- Release Date : 2021-08-20
- Total pages : 388
- ISBN : 9780128228333
GET BOOK
Summary : Overcoming Drug Resistance in Gynecologic Cancers provides up-to-date information related to important gynecologic cancers and focuses on mechanisms of drug resistance, genetics, signaling, immunology, health disparities, nanotechnology, economic considerations and financial impacts. The book covers not only drug resistance but also important means to reverse resistance both in the laboratory ...
- Author : Chunfu Wu,Lihui Wang
- Publisher : Academic Press
- Release Date : 2021-06-26
- Total pages : 144
- ISBN : 9780128228333
GET BOOK
Summary : Epigenetic Regulation in Overcoming Chemoresistance, Volume 19, explains how epigenetic agents can enhance the chemotherapy sensitivity of diverse types of cancers. The book provides a comprehensive delineation and the recent development of the scientific studies on the epigenetic regulation in enhancing chemo-sensitivity. In addition, it discusses several topics such as DNA ...
- Author : Ramasamy Paulmurugan,Tarik F. Massoud
- Publisher : Academic Press
- Release Date : 2021-06-25
- Total pages : 828
- ISBN : 9780128228333
GET BOOK
Summary : Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies brings current knowledge from an international team of experts on the science and clinical management of glioblastoma chemoresistance. The book discusses topics such as molecular mechanisms of chemoresistance, experimental models to study chemoresistance, chemoresistance to drugs other than Temozolomide, and ...
- Author : Yu-Chieh Wang
- Publisher : Unknown
- Release Date : 2008
- Total pages : 212
- ISBN : 9780128228333
GET BOOK
Summary : Abstract: Pre-existing and acquired resistance to epidermal growth factor receptor (EGFR) inhibitors limits their clinical usefulness in patients with advanced non-small cell lung cancer (NSCLC). In this dissertation research work, the in vitro/in vivo efficacy and mechanisms of the combination of gefitinib or erlotinib with OSU-03012, a celecoxib-derived antitumor ...
- Author : Yuichi Takiguchi
- Publisher : Springer
- Release Date : 2017-01-24
- Total pages : 327
- ISBN : 9780128228333
GET BOOK
Summary : This book discusses the latest molecular targeted therapy of lung cancer including its evaluation and future directions. It clearly illustrates the initial dramatic effectiveness of molecular targeted therapy, recurrence of the disease, overcoming the wide variety of resistance mechanisms using new-generation molecular targeted agents and potential novel approaches. It also ...
- Author : Ali Syed Arbab
- Publisher : Academic Press
- Release Date : 2021-03-18
- Total pages : 202
- ISBN : 9780128228333
GET BOOK
Summary : New Targeting in The Reversal of Resistant Glioblastomas discusses alternative treatment strategies that not only target tumor cells but also target the tumor microenvironment, metabolic pathways and interaction of cytokines in tumor cells. The current treatment for primary and recurrent glioblastomas is failing because clinicians are not considering the effect ...
- Author : Mauro Bologna
- Publisher : Springer Science & Business Media
- Release Date : 2012-04-05
- Total pages : 563
- ISBN : 9780128228333
GET BOOK
Summary : Biotargets of Cancer in Current Clinical Practice presents an updated and reasoned review of the current status of knowledge concerning the major cancer types with a special focus on the current biomarkers, genes involved and the potential future targets of innovative therapies. The volume includes for each major cancer type, ...
- Author : Aamir Ahmad,Shirish M. Gadgeel
- Publisher : Springer
- Release Date : 2015-12-24
- Total pages : 231
- ISBN : 9780128228333
GET BOOK
Summary : This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeutic targets such as EMT, cancer stem cells, and the tumor microenvironment; current personalized clinical management and radiation therapy for lung cancers; and ...
- Author : American Association for Cancer Research (AACR)
- Publisher : CTI Meeting Technology
- Release Date : 2016-03-28
- Total pages : 212
- ISBN : 9780128228333
GET BOOK
Summary : The AACR Annual Meeting is a must-attend event for cancer researchers and the broader cancer community. This year's theme, "Delivering Cures Through Cancer Science," reinforces the inextricable link between research and advances in patient care. The theme will be evident throughout the meeting as the latest, most exciting discoveries are ...
